top of page
Executive Spotlights

Orion Acquires Majority Stake in Biotech Startup LegoChem for $415M

Daejeon, Republic of Korea, January 15, 2024 (KED Global) -- Orion is investing $415.6 million to acquire a 25 percent stake in biotech company LegoChem Biosciences, thus becoming its largest shareholder. LegoChem Bio specializes in drug discovery, particularly in antibody-drug conjugates (ADC). Orion aims to leverage these ADC to break into the market of next-generation anticancer drugs.

Read full article here.

Recent Posts

See All

Radiant Vision Systems Appoints new CEO

Redmond, WA, July 1, 2024 (Radiant) -- Radiant Vision Systems has appointed Stone Jiang as their new CEO, succeeding Doug Kreysar who is retiring. Jiang, previously the Executive Vice President and

Orion and Merck Secure $1.63B Agreement

Rahway, NJ, July 1, 2024 (Business Wire) -- Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, and Orion Corporation ("Orion") have agreed to convert their co-development and co-commercial


Life Science Headlines
bottom of page